Showing results (401-410 of 537) with videos related to
Sort By:
Pageof 54
Arthritis Research & Therapy|August 4, 2019
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulationsIain B McInnes, Nicole L Byers, Richard E Higgs, et al.Annals of the Rheumatic Diseases|August 21, 2007
The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritisM M Harnett, D E Kean, A Boitelle, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2010
IL-33 exacerbates autoantibody-induced arthritisDamo Xu, Hui-Rong Jiang, Yubin Li, et al.Lancet (London, England)|May 11, 2020
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trialIain B McInnes, Frank Behrens, Philip J Mease, et al.Annals of the Rheumatic Diseases|July 10, 2004
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritisJ van Holten, K Pavelka, J Vencovsky, et al.The Journal of Rheumatology|December 7, 2005
Synovial tissue analysis in clinical trialsBarry Bresnihan, Dominique Baeten, Gary S Firestein, et al.Annals of the Rheumatic Diseases|August 8, 2015
Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational studyXenofon Baraliakos, Babul Borah, Juergen Braun, et al.Arthritis Research & Therapy|October 8, 2016
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated diseaseEric Hatterer, Limin Shang, Pierre Simonet, et al.The American Journal of Pathology|August 8, 2012
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasisMark D Singh, Vicky King, Helen Baldwin, et al.Journal of Autoimmunity|January 27, 2023
C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune toleranceJ Malcolm, M H Nyirenda, J L Brown, et al.Pageof 54